Authors: Todryk, SM Tutt, AL Green, MHA Smallwood, JA Halanek, N Dalgleish, AG Glennie, MJ

Citation: Sm. Todryk et al., CD40 ligation for immunotherapy of solid tumours, J IMMUNOL M, 248(1-2), 2001, pp. 139-147

Authors: Wong, WM Vakis, SA Ayre, KR Ellwood, CN Howell, WM Tutt, AL Cawley, MID Smith, JL

Citation: Wm. Wong et al., Rheumatoid arthritis T cells produce Th1 cytokines in response to stimulation with a novel trispecific antibody directed against CD2, CD3, and CD28, SC J RHEUM, 29(5), 2000, pp. 282-287

Authors: Stockmeyer, B Dechant, M van Egmond, M Tutt, AL Sundarapandiyan, K Graziano, RF Repp, R Kalden, JR Gramatzki, M Glennie, MJ van de Winkel, JGJ Valerius, T

Citation: B. Stockmeyer et al., Triggering FC alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy, J IMMUNOL, 165(10), 2000, pp. 5954-5961

Authors: Honeychurch, J Tutt, AL Valerius, T Heijnen, IAFM Van de Winkel, JGJ Glennie, MJ

Citation: J. Honeychurch et al., Therapeutic efficacy of Fc gamma RI/CD64-directed bispecific antibodies inB-cell lymphoma, BLOOD, 96(10), 2000, pp. 3544-3552

Authors: Glennie, MJ Honeychurch, J French, RR Tutt, AL

Citation: Mj. Glennie et al., The application of monoclonal antibodies in the treatment of lymphoma, METH MOL M, 40, 2000, pp. 85-97

Authors: French, RR Chan, HTC Tutt, AL Glennie, MJ

Citation: Rr. French et al., CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help, NAT MED, 5(5), 1999, pp. 548-553